Arkolith/Insider Trading/ELVN/Form 4

Patel Anish

CHIEF OPERATING OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Jan 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2026Sell(S)243$28.50$7K215K
Jan 9, 2026Sell(S)48K$27.98$1.3M215K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001967163-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML